IR-MED Inc. has recently released an amendment to its management certification for the financial results ending December 31, 2024. This update, requested by OTC Markets Group, is a restatement of the original publication made on May 12, 2025. The company confirms that the information provided is accurate and complete to the best of its knowledge. The restated document highlights IR-MED Inc.'s compliance with SEC reporting obligations and other regulatory requirements. Additionally, the company maintains its commitment to timely disclose material information in line with U.S. federal securities laws. IR-MED Inc. assures stakeholders of its good standing and organized structure under the relevant jurisdictional laws.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。